SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matritech (NASDAQ - NMPS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gary Schneekloth who wrote (332)11/22/1996 1:59:00 PM
From: Bill Canfield   of 849
 
SAN FRANCISCO, Nov. 22 /PRNewswire/ -- Robertson, Stephens & Company
research analyst Mark Simon initiated coverage today on Matritech, Inc.
(NMPS) with a Buy rating. Matritech is a company with an enabling
technology and one that has already carried a product through the FDA.

"We believe the company could easily eliminate a number of health care
costs and high anxiety medical procedures," said Simon. The EPS
estimates for 1996 and 1997 are ($0.32) and ($0.22), respectively.

Robertson, Stephens & Company is a leading international investment
banking firm focused on emerging growth companies. The firm's 31 senior
research analysts cover over 440 companies.

The information contained herein is not a complete analysis of every
material fact respecting any company, industry or security. Although
opinions and estimates expressed herein reflect the current judgment of
the Firm, the information upon which such opinions and estimates are
based is not necessarily updated on a regular basis; when they are, the
date of the change in estimate will be noted. In addition, opinions and
estimates are subject to change without notice. This news release
contains forward-looking statements, which involve risks and
uncertainties. The Company's actual results may differ significantly
from the results described in the forward-looking statements. Factors
that might cause such a difference include, but are not limited to,
those discussed in the "Investment Risks". Robertson, Stephens &
Company LLC from time to time performs corporate finance services for
some companies described herein and may occasionally possess material,
nonpublic information regarding such companies. This information is not
used in the preparation of the opinions and estimates herein. Facts and
other information discussed have been obtained from sources considered
reliable but are not guaranteed. Robertson, Stephens & Company LLC, its
managing directors, its affiliates and/or its employees may have an
interest in the securities of the issue(s) described and may make
purchases or sales while this press release is in circulation.
Robertson, Stephens & Company LLC, a California Limited Partnership, is
located at 555 California Street, San Francisco, CA 94104, phone
415-781-9700. Robertson, Stephens & Company investment bankers are
members of all major exchanges.
SOURCE Robertson, Stephens & Co.

-0- 11/22/96 /CONTACT: Schyler Parsons,
415-693-3332, or Mark Simon, 415-693-3343, both of Robertson, Stephens &
Company/
CO: Robertson, Stephens & Co.; Matritech Inc. ST: California IN:
FIN MTC SU: RTG
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext